AM-095 is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 μM for recombinant human and mouse LPA1, respectively. In functional assays, AM-095 inhibitsLPA-driven chemotaxis of CHO cells overexpressing mouse LPA? (IC50 = 778 nM) and human A2058 melanoma cells (IC50 = 233 nM). MW: 456.49. Purity ≥98% by HPLC